Loading…

Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications

We report the longest follow-up of clinical and biochemical features of two previously reported adult mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) patients treated with liver transplantation (LT), adding information on a third, recently transplanted, patient. All three patients over...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neurology 2020-12, Vol.267 (12), p.3702-3710
Main Authors: D’Angelo, Roberto, Boschetti, Elisa, Amore, Giulia, Costa, Roberta, Pugliese, Alessia, Caporali, Leonardo, Gramegna, Laura Ludovica, Papa, Valentina, Vizioli, Luca, Capristo, Mariantonietta, Contin, Manuela, Mohamed, Susan, Cenacchi, Giovanna, Lodi, Raffaele, Morelli, Maria Cristina, Fasano, Luca, Pisani, Lara, Cescon, Matteo, Tonon, Caterina, Pinna, Antonio Daniele, Dotti, Maria Teresa, Sicurelli, Francesco, Scarpelli, Mauro, Filosto, Massimiliano, Casali, Carlo, Pironi, Loris, Carelli, Valerio, De Giorgio, Roberto, Rinaldi, Rita
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We report the longest follow-up of clinical and biochemical features of two previously reported adult mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) patients treated with liver transplantation (LT), adding information on a third, recently transplanted, patient. All three patients overcame the early post-operative period and tolerated immunosuppressive therapy. Plasma nucleoside levels dramatically decreased, with evidence of clinical improvement of ambulation and neuropathy. Conversely, other features of MNGIE, as gastrointestinal dysmotility, low weight, ophthalmoparesis, and leukoencephalopathy were essentially unchanged. A similar picture characterized two patients treated with allogenic hematopoietic stem cell transplantation (AHSCT). In conclusion, LT promptly and stably normalizes nucleoside imbalance in MNGIE, stabilizing or improving some clinical parameters with marginal periprocedural mortality rate as compared to AHSCT. Nevertheless, restoring thymidine phosphorylase (TP) activity, achieved by both LT and AHSCT, does not allow a full clinical recovery, probably due to consolidated cellular damage and/or incomplete enzymatic tissue replacement.
ISSN:0340-5354
1432-1459
DOI:10.1007/s00415-020-10051-x